Clinical trials for both CLBP and CHF have not been run in Japan. As for Remestemcel-L - Temcell , I belive JCR have developement rights.
Cell Therapy News/Articles, page-15049
-
- There are more pages in this discussion • 2,978 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $1.168M | 1.221M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 183419 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 84093 | 38 |
View Market Depth
| Last trade - 12.56pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |